Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Exchange Rate Effect (2018 - 2025)

Historic Exchange Rate Effect for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to -$1000.0.

  • X4 Pharmaceuticals' Exchange Rate Effect fell 10060.61% to -$1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$34000.0, marking a year-over-year decrease of 11581.4%. This contributed to the annual value of -$156000.0 for FY2024, which is 25757.58% down from last year.
  • According to the latest figures from Q3 2025, X4 Pharmaceuticals' Exchange Rate Effect is -$1000.0, which was down 10060.61% from $139000.0 recorded in Q2 2025.
  • Over the past 5 years, X4 Pharmaceuticals' Exchange Rate Effect peaked at $363000.0 during Q4 2022, and registered a low of -$244000.0 during Q4 2024.
  • Moreover, its 5-year median value for Exchange Rate Effect was -$18000.0 (2024), whereas its average is -$14263.2.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first crashed by 60500.0% in 2022, then soared by 87222.22% in 2025.
  • Over the past 5 years, X4 Pharmaceuticals' Exchange Rate Effect (Quarter) stood at -$116000.0 in 2021, then skyrocketed by 412.93% to $363000.0 in 2022, then tumbled by 65.01% to $127000.0 in 2023, then plummeted by 292.13% to -$244000.0 in 2024, then soared by 99.59% to -$1000.0 in 2025.
  • Its last three reported values are -$1000.0 in Q3 2025, $139000.0 for Q2 2025, and $72000.0 during Q1 2025.